Literature DB >> 11379823

Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype.

A Verkkoniemi1, H Kalimo, A Paetau, M Somer, T Iwatsubo, J Hardy, M Haltia.   

Abstract

Variant Alzheimer disease (varAD) is clinically characterized by the combination of presenile dementia with spastic paraparesis and is caused by certain mutations of the presenilin 1 (PS-1) gene. We now present the unusual neuropathological phenotype of varAD as seen in 5 affected members of the original Finnish family with a genomic deletion encompassing exon 9 of the PS-1 gene. Their primary and association cortices and hippocampus showed a profusion of eosinophilic, roundish structures with distinct borders termed "cotton wool" plaques (CWPs). The CWPs were immunoreactive for Abeta42/43 but weakly or not at all for Abeta40 isoforms of the amyloid beta peptide (Abeta). They were devoid of a congophilic core, and fibrillar amyloid could not be identified within them by electron microscopy. Confocal microscopy showed reduced density of axons within individual CWPs and only few CWP-related PHF-tau-positive dystrophic neurites. CWPs were particularly numerous in the medial motor cortex representing the lower extremities, and degeneration of the lateral corticospinal tracts was observed at the level of the medulla oblongata and the spinal cord. In addition to the predominant CWPs, variable numbers of diffuse and cored plaques were found in the cerebral cortex. Diffuse and non-neuritic cored amyloid plaques but no CWPs occurred in the cerebellum. In conclusion, varAD in this Finnish family is distinct from classic AD because of the degeneration of lateral corticospinal tracts, predominance of CWPs devoid of fibrillar amyloid cores in the cerebral cortex, and presence of non-neuritic amyloid plaques in the cerebellum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379823     DOI: 10.1093/jnen/60.5.483

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

1.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 2.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

3.  Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1.

Authors:  Leslie A Rudzinski; Rita M Fletcher; Dennis W Dickson; Richard Crook; Michael L Hutton; Jennifer Adamson; Neill R Graff-Radford
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

4.  Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.

Authors:  Paul O'Callaghan; Elina Sandwall; Jin-Ping Li; Hong Yu; Rivka Ravid; Zhi-Zhong Guan; Toin H van Kuppevelt; Lars N G Nilsson; Martin Ingelsson; Bradley T Hyman; Hannu Kalimo; Ulf Lindahl; Lars Lannfelt; Xiao Zhang
Journal:  Brain Pathol       Date:  2008-04-11       Impact factor: 6.508

5.  Forgetful and robotic: tap on a gene!

Authors:  Lucio Tremolizzo; E Susani; D Binda; F Bertola; C Ferrarese; I Appollonio
Journal:  Neurol Sci       Date:  2015-01-08       Impact factor: 3.307

Review 6.  Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2011-06-12       Impact factor: 6.817

Review 7.  The role of novel chitin-like polysaccharides in Alzheimer disease.

Authors:  Rudy J Castellani; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

8.  Comparison of 18F-FDG and PiB PET in cognitive impairment.

Authors:  Val J Lowe; Bradley J Kemp; Clifford R Jack; Matthew Senjem; Stephen Weigand; Maria Shiung; Glenn Smith; David Knopman; Bradley Boeve; Brian Mullan; Ronald C Petersen
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

9.  Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.

Authors:  Steffan K Soosman; Nelly Joseph-Mathurin; Meredith N Braskie; Yvette M Bordelon; David Wharton; Maria Casado; Giovanni Coppola; Holly McCallum; Marc Nuwer; Pedro Coutin-Churchman; Liana G Apostolova; Tammie Benzinger; John M Ringman
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

10.  Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.

Authors:  John M Ringman; Luis D Medina; Yaneth Rodriguez-Agudelo; Mireya Chavez; Po Lu; Jeffrey L Cummings
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.